The GLP is committed to full transparency. Download and review our 2019 Annual Report

Update on gene therapy

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Researchers at the Spanish National Cancer Research Centre (CNIO) published proof-of-principle results showing a role for telomerase reverse transcriptase (TERT) in demonstrating the feasibility of gene therapy in delaying physiological aging and extending longevity in normal mice.

View the original article here: Gene Therapy Briefs – Genetic Engineering News

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend